Skip to content
BidSonarBidSonar

Awarded contract

NHS Type 2 Diabetes Remission Programme - Dorset (Wave 4)

Deliver weight management and lifestyle interventions to help type 2 diabetes patients achieve remission across Dorset.

Published 19 Jun 2026 · 5 months agoContracts Finder

View on sourceContracts Finder

Award notice and full record on the publisher's site

Tender closed

31 Mar 2026

7 months ago

Contract value

£209,275

Pounds sterling

Sector

Healthcare & Medical

Browse related listings

Location

United Kingdom

Publisher
UK Cabinet Office
Licence
OGL v3.0
Record ID
cfaaa919-b756-4e7f-93d9-864eacf02939-902773

Suppliers

1 supplier

Lifecycle

Contract awarded. Originally published 5 months ago.

Awarded
  1. Tender deadline31 Mar 202634 weeks ago
  2. Published19 Jun 20265 months ago

Brief

This is an opportunity to deliver the NHS Type 2 Diabetes Path to Remission Programme in Dorset as part of Wave 4 Lot 5. The programme aims to help patients with type 2 diabetes achieve remission through structured weight management and lifestyle intervention services. Successful bidders will work with NHS commissioners to implement evidence-based weight loss and diabetes management interventions across Dorset, supporting patients to lose weight and potentially achieve remission of their type 2 diabetes diagnosis. This is part of a wider NHS initiative to expand remission-focused care pathways.

Track record

Open field. No single supplier dominates the field.

127 awards · 90 winners

In this category, NHS ENGLAND has awarded 127 contracts to 90 suppliers.

Who wins here

  1. OVIVA UK LIMITED12× · 9%

+84 more suppliers

Across this category, the most active winners are CARE LINE HOMECARE LIMITED, SPRINGFIELD HOME CARE SERVICES LIMITED, HERTS and ESSEX FERTILITY CENTRE LIMITED — the field to beat, or your route in as a partner.

Ask an assistant

Add BidSonar to the assistant you already use, then ask it about this notice in plain English.

More from NHS ENGLAND

4 listingsView all

NHS Fidaxomicin Supply Framework

NHS ENGLAND

NHS England invites fidaxomicin suppliers to express interest in a national supply framework with anticipated growth in demand.

PlannedHealthcare & MedicalUnited KingdomPublished 17 Nov 2026

est.£22,320,000

Open in Healthcare & Medical

4 open listingsView all